Volume 40, Issue 2 pp. 120-125
Full Access

Different Ability of Trifluoperazine to Inhibit Agonist-induced Contraction of Lung Parenchyma Strips from Control and Sensitized Guinea-pigs

Celia Sanz

Celia Sanz

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain

Search for more papers by this author
Julio Cortijo

Julio Cortijo

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain

Search for more papers by this author
Miguel Perpin̄á

Miguel Perpin̄á

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain

Search for more papers by this author
Juan Esplugues

Juan Esplugues

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain

Search for more papers by this author
Esteban J. Morcillo

Corresponding Author

Esteban J. Morcillo

Departamento de Farmacología, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain

Departamento de Farmacologia, Facultad de Medicina, Universidad de Valencia y Alcalá de Henares, Valencia, Spain.Search for more papers by this author
First published: February 1988
Citations: 8

Abstract

Abstract— There is increasing interest in the therapeutic potential of calcium antagonists in asthma. Among them the use of calmodulin antagonists deserves consideration. In the present work the effect of trifluoperazine on contractions generated by different mechanisms (CaCl2, KCl, acetylcholine, histamine and 5-hydroxytryptamine) in lung parenchyma strip isolated from control and actively sensitized guinea-pigs has been studied. Trifluoperazine produced both in unsensitized and sensitized lung strips, a concentration-dependent, right, downward displacement of the concentration-response curves to the agonists used, although the sensitization procedure resulted in a potentiation in the ability of trifluoperazine to inhibit agonist-induced contractions. The basis for this greater potency of trifluoperazine in sensitized tissues remains to be elucidated but raises attention to the future use of selective calmodulin antagonists in the management of asthma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.